Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03353376
Other study ID # JSMG-01
Secondary ID
Status Completed
Phase N/A
First received November 2, 2017
Last updated November 22, 2017
Start date September 13, 2010
Est. completion date January 2, 2014

Study information

Verified date October 2017
Source Rabin Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this prospective, randomized, non blinded, one center (University hospital) trial, 60 patients (28 with type 1 and 32 with type 2 diabetes) with a mean duration of diabetes of 22.5 ± 11.7 years were randomly assigned to group (6 patients per group) or individual usual care for one year. Primary end-point included change in Hba1c and visits to out-patients clinics, secondary endpoint included change in body mass index, blood pressure levels, waist circumference, non HDL Cholesterol, diabetes related and quality of life questionnaires and hospitalizations.


Description:

in the intervention arm patients attended 4 preplanned group visits in the study year and the empowerment model was used in the group care visits.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 2, 2014
Est. primary completion date January 2, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of type 1 or type 2 diabetes

- Fluency in Hebrew

- Attendance at least for the second time at the diabetes clinic

- Follow up of at least one year by a general practitioner

- Willingness to participate in the study and to give informed consent.

Exclusion Criteria:

- Uncontrolled psychiatric diseases

- Active cancer

- Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
group care with Empowerment model
Patients with type 2 and type 1 diabetes were followed in a tertiary outpatient clinic with group appointment

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Rabin Medical Center

Outcome

Type Measure Description Time frame Safety issue
Other change in number of outpatients visits Collection of data at start and after one year one year from date of randomization
Other change in number in hospital admission Collection of data at start and end of study from electronic files one year from date of randomization
Primary change in in Hba1c levels Collection of data at start and after one year one year from date of randomization
Secondary change in scores of diabetes specific questionnaire Collection of data at start and end of study from electronic files one year from date of randomization
Secondary change in BMI in kg/m2 Collection of data (weight in kg, height in meter) at start and end of study from electronic files one year from date of randomization
Secondary change in non HDL Cholesterol Collection of data at start and end of study from electronic files one year from date of randomization
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A